These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1856146)

  • 1. Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin.
    Tulkens PM
    J Antimicrob Chemother; 1991 May; 27 Suppl C():49-61. PubMed ID: 1856146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease.
    Ibrahim S; Derde MP; Kaufman L; Clerckx-Braun F; Jacqmin P; Brulein V; Donnez J; Tulkens PM
    Ren Fail; 1990; 12(3):199-203. PubMed ID: 2287773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity, high frequency ototoxicity, efficacy and serum kinetics of once versus thrice daily dosing of netilmicin in patients with serious infections.
    Blaser J; Simmen HP; Thurnheer U; König C; Lüthy R
    J Antimicrob Chemother; 1995 Nov; 36(5):803-14. PubMed ID: 8626261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections.
    Hollender LF; Bahnini J; De Manzini N; Lau WY; Fan ST; Hermansyur K; Benny P; Husni AN; Sutjipto ; Lorber RR
    J Antimicrob Chemother; 1989 May; 23(5):773-83. PubMed ID: 2668247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection.
    Van der Auwera P; Meunier F; Ibrahim S; Kaufman L; Derde MP; Tulkens PM
    Antimicrob Agents Chemother; 1991 Apr; 35(4):640-7. PubMed ID: 2069370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides.
    El Mouedden M; Laurent G; Mingeot-Leclercq MP; Taper HS; Cumps J; Tulkens PM
    Antimicrob Agents Chemother; 2000 Mar; 44(3):665-75. PubMed ID: 10681336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients.
    Rozdzinski E; Kern WV; Reichle A; Moritz T; Schmeiser T; Gaus W; Kurrle E
    J Antimicrob Chemother; 1993 Apr; 31(4):585-98. PubMed ID: 8514653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of different dosing regimens of the aminoglycosides netilmicin and amikacin on vestibulotoxicity in the guinea pig.
    Pettorossi VE; Ferraresi A; Errico P; Draicchio F; Dionisotti S
    Eur Arch Otorhinolaryngol; 1990; 247(5):277-82. PubMed ID: 2393560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect and pharmacokinetics of netilmicin given as bolus intramuscular administration: an open comparative trial versus amikacin and fosfomycin in elderly patients affected by urinary tract infections.
    Caramalli S; Amprimo MC; Cavalli G; Mantelli M; Pollastrelli E; Raiteri F; Varese LA; Franchino L
    Int J Clin Pharmacol Res; 1991; 11(2):55-65. PubMed ID: 1879990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity.
    Barza M; Lauermann MW; Tally FP; Gorbach SL
    Antimicrob Agents Chemother; 1980 Apr; 17(4):707-14. PubMed ID: 6994638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients.
    Marik PE; Lipman J; Kobilski S; Scribante J
    J Antimicrob Chemother; 1991 Nov; 28(5):753-64. PubMed ID: 1778878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone.
    ter Braak EW; de Vries PJ; Bouter KP; van der Vegt SG; Dorrestein GC; Nortier JW; van Dijk A; Verkooyen RP; Verbrugh HA
    Am J Med; 1990 Jul; 89(1):58-66. PubMed ID: 2195890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily gentamicin versus once-daily netilmicin in patients with serious infections--a randomized clinical trial.
    Prins JM; Büller HR; Kuijper EJ; Tange RA; Speelman P
    J Antimicrob Chemother; 1994 Apr; 33(4):823-35. PubMed ID: 8056701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance of once-daily dosing of netilmicin and teicoplanin, alone or in combination, in healthy volunteers.
    Pierre C; Blanchet F; Seta N; Chaigne P; Labarre C; Sterkers O; Amiel C; Carbon C
    Clin Pharmacol Ther; 1988 Oct; 44(4):458-66. PubMed ID: 2971498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
    Olier B; Morin JP; Thomas N; Fillastre JP
    Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A series of clinical study on netilmicin].
    Ji S; Wang R; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jun; 22(6):354-7. PubMed ID: 11775826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?
    Nordström L; Ringberg H; Cronberg S; Tjernström O; Walder M
    J Antimicrob Chemother; 1990 Jan; 25(1):159-73. PubMed ID: 2108113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the ototoxicity of amikacin and netilmicin using provoked acoustic oto-emissions and high-frequency audiometry].
    Collet L; Veuillet E; Chanal JM; Desreux V; Mermet B; Disant F; Morgon A
    Pathol Biol (Paris); 1992 Dec; 40(10):990-2. PubMed ID: 1299814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity.
    Langhendries JP; Battisti O; Bertrand JM; François A; Darimont J; Ibrahim S; Tulkens PM; Bernard A; Buchet JP; Scalais E
    Dev Pharmacol Ther; 1993; 20(3-4):220-30. PubMed ID: 7828457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.